AKT1 and Insulin resistance: SELENOP is a well-known hepatokine to cause insulin resistance, which reduces phosphorylated AKT in liver and muscle, and decreases the number of pancreas β cells and GSIS (Misu et al, 2010; Mita et al, 2017).